Ajay Royan Biography and Net Worth

Director of Fractyl Health

Ajay Royan created and runs Mithril, a growth fund that makes concentrated investments in transformative and durable technology companies around the world.

Ajay and his team partner with innovators building companies in industries as diverse as cybersecurity, advanced medical devices, and fusion energy. Before forming Mithril, Ajay was a member of the core team that grew Clarium Capital into a multibillion-dollar macro fund.

He serves as an external advisor to Oak Ridge National Labs and the University of Michigan Risk Science Center. He was educated at Yale.

What is Ajay Royan's net worth?: The estimated net worth of Ajay Royan is at least $30.34 thousand as of June 12th, 2026. Mr. Royan owns 40,901 shares of Fractyl Health stock worth more than $30,340 as of August 28th. This net worth approximation does not reflect any other assets that Mr. Royan may own. Learn More about Ajay Royan's net worth.
How do I contact Ajay Royan?: The corporate mailing address for Mr. Royan and other Fractyl Health executives is 17 Hartwell Avenue, Lexington, MA 02421, United States. Fractyl Health can also be reached via phone at 781-902-8800 and via email at [email protected]. Learn More on Ajay Royan's contact information.
Has Ajay Royan been buying or selling shares of Fractyl Health?: Ajay Royan has not been actively trading shares of Fractyl Health during the past quarter. Most recently, on Friday, June 12th, Ajay Royan bought 23,000 shares of Fractyl Health stock. The stock was acquired at an average cost of $0.85 per share, with a total value of $19,550.00. Following the completion of the transaction, the director now directly owns 40,901 shares of the company's stock, valued at $34,765.85. Learn More on Ajay Royan's trading history.
Are insiders buying or selling shares of Fractyl Health?: During the last twelve months, Fractyl Health insiders bought shares 6 times. They purchased a total of 181,909 shares worth more than $147,148.61. The most recent insider tranaction occured on June, 12th when Director Ajay Royan bought 23,000 shares worth more than $19,550.00. Insiders at Fractyl Health own 8.5% of the company. Learn More about insider trades at Fractyl Health.
Information on this page was last updated on 6/12/2026.

Ajay Royan Insider Trading History at Fractyl Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/12/2026	Buy	23,000	$0.85	$19,550.00	40,901
2/6/2024	Buy	333,333	$15.00	$4,999,995.00	1,251,900

Ajay Royan Buying and Selling Activity at Fractyl Health

Fractyl Health Company Overview

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $0.74

$0.74

$0.76

50 Day Range

MA: $0.75

$0.66

$0.91

2 Week Range

Now: $0.74

$0.38

$2.45

Volume

56,479 shs

Average Volume

3,196,592 shs

Market Capitalization

$117.94 million

P/E Ratio

N/A

Dividend Yield